Inborn Gene or Chromosome Alterations Tests – Medical Devices Pipeline Assessment, 2020

Inborn Gene or Chromosome Alterations Tests are the genetic tests used to detect monogenetic disorders (like Cystic Fibrosis, Haemochromatosis, Prothrombin Mutation etc), polygenetic disorders (like Asthma , Atherosclerosis, Diabetes, Hypertension, Osteoporosis, etc), chromosomal disorders (like Down’s Syndrome, Edwards Syndrome etc), polymorphisms (like HLA-Typing etc). GlobalData’s Medical Devices sector report, “Inborn Gene or Chromosome Alterations Tests – Medical Devices Pipeline Assessment, 2020″ provides comprehensive information about the Inborn Gene or Chromosome Alterations Tests pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.

The Inborn Gene or Chromosome Alterations Tests Pipeline Assessment report provides key information and data related to:

Extensive coverage of the Inborn Gene or Chromosome Alterations Tests under development

Review details of major pipeline products which include product description, licensing and collaboration details and other developmental activities including pipeline territories, regulatory paths and estimated approval dates

Reviews of major players involved in the pipeline product development.

Provides key clinical trial data related to ongoing clinical trials such as trial phase, trial status, trial start and end dates, and, the number of trials of the major Inborn Gene or Chromosome Alterations Tests pipeline products.

Review of Recent Developments in the segment / industry

The Inborn Gene or Chromosome Alterations Tests Pipeline Assessment report enables you to:

Access significant competitor information, analysis, and insights to improve your R&D strategies

Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

Identify and understand important and diverse types of Glaucoma Drainage Device sunder development

Formulate market-entry and market expansion strategies

Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline

The major companies covered in the “Inborn Gene or Chromosome Alterations Tests- Medical Devices Pipeline Assessment, 2020” report:

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

The GlobalData Differentiation

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData’s team of industry experts.

The data and analysis within this report are driven by GlobalData Medical Intelligence Center (GDMIC) database. GDMIC gives you the key information required to drive sales, investment and deal-making activity in your business. It includes the following:

• 15,000+ data tables showing market size across more than 780 medical equipment segments and 39 countries, from 2015 and forecast to 2025

• 6,700+ industry-leading analysis reports covering sector reports, medipoint reports, country analysis, expert insights and industry analysis (devices and procedures) reports

• 64,000+ medical equipment company profiles

• 5,600+ company profiles of medical equipment manufacturers in China and India

• 2,200+ company profiles of medical equipment manufacturers in Japan

• 1,200+ companies’ revenue splits and market shares

• 1,600+ quarterly and annual medical equipment company financials

• 850+ medical equipment company SWOTs

• 28,000+ pipeline product profiles

• 56,400+ marketed product profiles

• 47,000+ clinical trials

• 41,500+ trial investigators

• 7,000+ reports on companies with products in development

• 44,000+ deals in the medical equipment industry

• 1,100+ surgical and diagnostic procedures by therapy area

• 50+ key healthcare indicators by country

• 431,000+ Themes Content Items

• 600+ Influencers

• 1,900+ Analysts & Researchers

• 0.5m+ Community Members

• 141,000+ Macroeconomic Indicators

• 1,013,000+ City Indicators

For more information or to receive a free demonstration of the service, please visit:

https://medical.globaldata.com/home.aspx

Custom Requirements

Contact us to discuss the areas of your business where you need external input, and we will work with you to identify the strongest way forward to meet your needs.

Scope

Extensive coverage of the Inborn Gene or Chromosome Alterations Tests under development

The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities

The report reviews the major players involved in the development of Inborn Gene or Chromosome Alterations Tests and list all their pipeline projects

The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage

The report provides key clinical trial data of ongoing trials specific to pipeline products

Recent developments in the segment / industry

Reasons to buy

The report enables you to:

Formulate significant competitor information, analysis, and insights to improve R&D strategies

Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

Identify and understand important and diverse types of Inborn Gene or Chromosome Alterations Tests under development

Develop market-entry and market expansion strategies

Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline

In-depth analysis of the product’s current stage of development, territory and estimated launch date

Companies mentioned

Aarhus University

AbaStar MDx Inc

AC-Gen Reading Life S.L.

Agena Bioscience Inc

Alexion Pharmaceuticals Inc

Allele Diagnostics Inc

Amarantus Bioscience Holdings Inc

Amity University

Arrayit Corporation

Asuragen Inc

Augusta University

AutoGenomics Inc

Baylor College of Medicine

BioCeps (Inactive)

Biocept Inc

Biofidelity Ltd

Boston Children’s Hospital

Cardiff Oncology Inc

CareDx Inc

Celula Inc

Children’s Hospital of Philadelphia

China Medical Technologies Inc (Inactive)

ChipCare Corp

ChromaCode Inc

Chronix Biomedical Inc

Cincinnati Children’s Hospital Medical Center

Columbia University

Consejo Superior de Investigaciones Cientificas

Daan Gene Co Ltd

Decipher GenX, Inc.

Duke University

Echelon Diagnostics Inc

EGIS Pharmaceuticals Plc

Eone Diagnomics Genome Center Co Ltd

Epinex Diagnostics Inc

Fina Biotech SL

Firalis SAS

Fluidigm Corp

Fraunhofer Institute for Cell Therapy and Immunology

Fraunhofer-Gesellschaft zur Forderung der Angewandten Forschung eV

Fred Hutchinson Cancer Research Center

French National Institute of Health and Medical Research

genedrive plc

Genentech USA Inc

Genisphere LLC

Genomic Vision SA

genomiQa Pty Ltd

German Cancer Research Center

German Institute of Human Nutrition

Gilupi GmbH

GnuBIO Inc

Hadassah Medical Center

Hebrew University of Jerusalem

Helicos BioSciences Corporation

Helmholtz Zentrum Munchen Deutsches Forschungszentrum fur Gesundheit und Umwelt (GmbH)

Hummingbird Diagnostics GmbH

iGene Laboratory Pte Ltd

Illumina Inc

Indiana University

Interpace Biosciences Inc

iXlayer Inc

Johns Hopkins University

JS Genetics Inc

Juneau Biosciences LLC

KellBenx Inc (Inactive)

Laboratory Corp of America Holdings

Laval University

LifeCodexx AG

LineaGen Inc

Lucid Diagnostics Inc

Maastricht University Medical Center

Massachusetts Eye and Ear Infirmary

Max Delbruck Center for Molecular Medicine

McGill University

Medical Research Council

MeMed Diagnostics LTD

Myriad Genetics Inc

Nanosphere Inc

National Jewish Health

National University of Singapore

Nel ASA

NewGene Ltd

NIPD Genetics

Oxford Biodynamics Plc

Oxford Gene Technology Ltd

ParagonDx LLC (Inactive)

PerkinElmer Inc

Population Bio Inc

Precipio Inc

PreCyte, Inc.

PredictImmune Ltd

Predictive Therapeutics LLC

Predigen Inc

Progenity Inc

Proove BioScience Inc

Quest Diagnostics Inc

Roche Diagnostics International Ltd

Sapien Biosciences

Scipher Medicine Corp

Seattle Children’s Hospital

Seegene Inc

Sequenom Inc

Sheba Medical Center

SkylineDx BV

Sophia Genetics SA

StellarGene Technologies Pvt Ltd

Strand Life Sciences Pvt Ltd

SUNY Upstate Medical University

Takeda Pharmaceuticals International AG

TAmiRNA GmbH

TBG Diagnostics Ltd

Tel Aviv University

The Francis Crick Institute Ltd

thromboDx

Transplant Genomics Inc

Tufts Medical Center

University Hospital of Cologne

University of Arizona

University of California San Diego

University of California San Francisco

University of Cambridge

University of Cape Town

University of Central Florida

University of Colorado

University of Illinois at Chicago

University of Melbourne

University of Michigan

University of Oxford

University of Pennsylvania

University of Pittsburgh

University of Turku

Vanadis Diagnostics AB

Vanderbilt University

Vanessa Research Inc

Virginia Commonwealth University

VitaPath Genetics, Inc.

Yale University

Table of Contents

1 Table of Contents 2

1.1 List of Tables 9

1.2 List of Figures 20

2 Introduction 21

2.1 Inborn Gene or Chromosome Alterations Overview 21

3 Products under Development 22

3.1 Inborn Gene or Chromosome Alterations – Pipeline Products by Stage of Development 22

3.2 Inborn Gene or Chromosome Alterations – Pipeline Products by Territory 23

3.3 Inborn Gene or Chromosome Alterations – Pipeline Products by Regulatory Path 24

3.4 Inborn Gene or Chromosome Alterations – Pipeline Products by Estimated Approval Date 25

3.5 Inborn Gene or Chromosome Alterations – Ongoing Clinical Trials 26

4 Inborn Gene or Chromosome Alterations – Pipeline Products under Development by Companies 27

4.1 Inborn Gene or Chromosome Alterations Companies – Pipeline Products by Stage of Development 27

4.2 Inborn Gene or Chromosome Alterations – Pipeline Products by Stage of Development 31

5 Inborn Gene or Chromosome Alterations Companies and Product Overview 38

5.1 Aarhus University Company Overview 38

5.1.1 Aarhus University Pipeline Products & Ongoing Clinical Trials Overview 38

5.2 AbaStar MDx Inc Company Overview 39

5.2.1 AbaStar MDx Inc Pipeline Products & Ongoing Clinical Trials Overview 39

5.3 AC-Gen Reading Life S.L. Company Overview 42

5.3.1 AC-Gen Reading Life S.L. Pipeline Products & Ongoing Clinical Trials Overview 42

5.4 Agena Bioscience Inc Company Overview 43

5.4.1 Agena Bioscience Inc Pipeline Products & Ongoing Clinical Trials Overview 43

5.5 Alexion Pharmaceuticals Inc Company Overview 44

5.5.1 Alexion Pharmaceuticals Inc Pipeline Products & Ongoing Clinical Trials Overview 44

5.6 Allele Diagnostics Inc Company Overview 45

5.6.1 Allele Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview 45

5.7 Amarantus Bioscience Holdings Inc Company Overview 46

5.7.1 Amarantus Bioscience Holdings Inc Pipeline Products & Ongoing Clinical Trials Overview 46

5.8 Amity University Company Overview 47

5.8.1 Amity University Pipeline Products & Ongoing Clinical Trials Overview 47

5.9 Arrayit Corporation Company Overview 48

5.9.1 Arrayit Corporation Pipeline Products & Ongoing Clinical Trials Overview 48

5.10 Asuragen Inc Company Overview 49

5.10.1 Asuragen Inc Pipeline Products & Ongoing Clinical Trials Overview 49

5.11 Augusta University Company Overview 50

5.11.1 Augusta University Pipeline Products & Ongoing Clinical Trials Overview 50

5.12 AutoGenomics Inc Company Overview 51

5.12.1 AutoGenomics Inc Pipeline Products & Ongoing Clinical Trials Overview 51

5.13 Baylor College of Medicine Company Overview 54

5.13.1 Baylor College of Medicine Pipeline Products & Ongoing Clinical Trials Overview 54

5.14 BioCeps (Inactive) Company Overview 55

5.14.1 BioCeps (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 55

5.15 Biocept Inc Company Overview 56

5.15.1 Biocept Inc Pipeline Products & Ongoing Clinical Trials Overview 56

5.16 Biofidelity Ltd Company Overview 57

5.16.1 Biofidelity Ltd Pipeline Products & Ongoing Clinical Trials Overview 57

5.17 Boston Children’s Hospital Company Overview 58

5.17.1 Boston Children’s Hospital Pipeline Products & Ongoing Clinical Trials Overview 58

5.18 Cardiff Oncology Inc Company Overview 60

5.18.1 Cardiff Oncology Inc Pipeline Products & Ongoing Clinical Trials Overview 60

5.19 CareDx Inc Company Overview 61

5.19.1 CareDx Inc Pipeline Products & Ongoing Clinical Trials Overview 61

5.20 Celula Inc Company Overview 65

5.20.1 Celula Inc Pipeline Products & Ongoing Clinical Trials Overview 65

5.21 Children’s Hospital of Philadelphia Company Overview 66

5.21.1 Children’s Hospital of Philadelphia Pipeline Products & Ongoing Clinical Trials Overview 66

5.22 China Medical Technologies Inc (Inactive) Company Overview 67

5.22.1 China Medical Technologies Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 67

5.23 ChipCare Corp Company Overview 68

5.23.1 ChipCare Corp Pipeline Products & Ongoing Clinical Trials Overview 68

5.24 ChromaCode Inc Company Overview 69

5.24.1 ChromaCode Inc Pipeline Products & Ongoing Clinical Trials Overview 69

5.25 Chronix Biomedical Inc Company Overview 70

5.25.1 Chronix Biomedical Inc Pipeline Products & Ongoing Clinical Trials Overview 70

5.26 Cincinnati Children’s Hospital Medical Center Company Overview 71

5.26.1 Cincinnati Children’s Hospital Medical Center Pipeline Products & Ongoing Clinical Trials Overview 71

5.27 Columbia University Company Overview 75

5.27.1 Columbia University Pipeline Products & Ongoing Clinical Trials Overview 75

5.28 Consejo Superior de Investigaciones Cientificas Company Overview 77

5.28.1 Consejo Superior de Investigaciones Cientificas Pipeline Products & Ongoing Clinical Trials Overview 77

5.29 Daan Gene Co Ltd Company Overview 78

5.29.1 Daan Gene Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 78

5.30 Decipher GenX, Inc. Company Overview 79

5.30.1 Decipher GenX, Inc. Pipeline Products & Ongoing Clinical Trials Overview 79

5.31 Duke University Company Overview 80

5.31.1 Duke University Pipeline Products & Ongoing Clinical Trials Overview 80

5.32 Echelon Diagnostics Inc Company Overview 81

5.32.1 Echelon Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview 81

5.33 EGIS Pharmaceuticals Plc Company Overview 82

5.33.1 EGIS Pharmaceuticals Plc Pipeline Products & Ongoing Clinical Trials Overview 82

5.34 Eone Diagnomics Genome Center Co Ltd Company Overview 83

5.34.1 Eone Diagnomics Genome Center Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 83

5.35 Epinex Diagnostics Inc Company Overview 87

5.35.1 Epinex Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview 87

5.36 Fina Biotech SL Company Overview 88

5.36.1 Fina Biotech SL Pipeline Products & Ongoing Clinical Trials Overview 88

5.37 Firalis SAS Company Overview 89

5.37.1 Firalis SAS Pipeline Products & Ongoing Clinical Trials Overview 89

5.38 Fluidigm Corp Company Overview 90

5.38.1 Fluidigm Corp Pipeline Products & Ongoing Clinical Trials Overview 90

5.39 Fraunhofer Institute for Cell Therapy and Immunology Company Overview 91

5.39.1 Fraunhofer Institute for Cell Therapy and Immunology Pipeline Products & Ongoing Clinical Trials Overview 91

5.40 Fraunhofer-Gesellschaft zur Forderung der Angewandten Forschung eV Company Overview 92

5.40.1 Fraunhofer-Gesellschaft zur Forderung der Angewandten Forschung eV Pipeline Products & Ongoing Clinical Trials Overview 92

5.41 Fred Hutchinson Cancer Research Center Company Overview 93

5.41.1 Fred Hutchinson Cancer Research Center Pipeline Products & Ongoing Clinical Trials Overview 93

5.42 French National Institute of Health and Medical Research Company Overview 95

5.42.1 French National Institute of Health and Medical Research Pipeline Products & Ongoing Clinical Trials Overview 95

5.43 genedrive plc Company Overview 98

5.43.1 genedrive plc Pipeline Products & Ongoing Clinical Trials Overview 98

5.44 Genentech USA Inc Company Overview 101

5.44.1 Genentech USA Inc Pipeline Products & Ongoing Clinical Trials Overview 101

5.45 Genisphere LLC Company Overview 102

5.45.1 Genisphere LLC Pipeline Products & Ongoing Clinical Trials Overview 102

5.46 Genomic Vision SA Company Overview 103

5.46.1 Genomic Vision SA Pipeline Products & Ongoing Clinical Trials Overview 103

5.47 genomiQa Pty Ltd Company Overview 104

5.47.1 genomiQa Pty Ltd Pipeline Products & Ongoing Clinical Trials Overview 104

5.48 German Cancer Research Center Company Overview 108

5.48.1 German Cancer Research Center Pipeline Products & Ongoing Clinical Trials Overview 108

5.49 German Institute of Human Nutrition Company Overview 111

5.49.1 German Institute of Human Nutrition Pipeline Products & Ongoing Clinical Trials Overview 111

5.50 Gilupi GmbH Company Overview 112

5.50.1 Gilupi GmbH Pipeline Products & Ongoing Clinical Trials Overview 112

5.51 GnuBIO Inc Company Overview 113

5.51.1 GnuBIO Inc Pipeline Products & Ongoing Clinical Trials Overview 113

5.52 Hadassah Medical Center Company Overview 114

5.52.1 Hadassah Medical Center Pipeline Products & Ongoing Clinical Trials Overview 114

5.53 Hebrew University of Jerusalem Company Overview 115

5.53.1 Hebrew University of Jerusalem Pipeline Products & Ongoing Clinical Trials Overview 115

5.54 Helicos BioSciences Corporation Company Overview 116

5.54.1 Helicos BioSciences Corporation Pipeline Products & Ongoing Clinical Trials Overview 116

5.55 Helmholtz Zentrum Munchen Deutsches Forschungszentrum fur Gesundheit und Umwelt (GmbH) Company Overview 117

5.55.1 Helmholtz Zentrum Munchen Deutsches Forschungszentrum fur Gesundheit und Umwelt (GmbH) Pipeline Products & Ongoing Clinical Trials Overview 117

5.56 Hummingbird Diagnostics GmbH Company Overview 119

5.56.1 Hummingbird Diagnostics GmbH Pipeline Products & Ongoing Clinical Trials Overview 119

5.57 iGene Laboratory Pte Ltd Company Overview 120

5.57.1 iGene Laboratory Pte Ltd Pipeline Products & Ongoing Clinical Trials Overview 120

5.58 Illumina Inc Company Overview 121

5.58.1 Illumina Inc Pipeline Products & Ongoing Clinical Trials Overview 121

5.59 Indiana University Company Overview 123

5.59.1 Indiana University Pipeline Products & Ongoing Clinical Trials Overview 123

5.60 Interpace Biosciences Inc Company Overview 124

5.60.1 Interpace Biosciences Inc Pipeline Products & Ongoing Clinical Trials Overview 124

5.61 iXlayer Inc Company Overview 129

5.61.1 iXlayer Inc Pipeline Products & Ongoing Clinical Trials Overview 129

5.62 Johns Hopkins University Company Overview 130

5.62.1 Johns Hopkins University Pipeline Products & Ongoing Clinical Trials Overview 130

5.63 JS Genetics Inc Company Overview 133

5.63.1 JS Genetics Inc Pipeline Products & Ongoing Clinical Trials Overview 133

5.64 Juneau Biosciences LLC Company Overview 134

5.64.1 Juneau Biosciences LLC Pipeline Products & Ongoing Clinical Trials Overview 134

5.65 KellBenx Inc (Inactive) Company Overview 135

5.65.1 KellBenx Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 135

5.66 Laboratory Corp of America Holdings Company Overview 136

5.66.1 Laboratory Corp of America Holdings Pipeline Products & Ongoing Clinical Trials Overview 136

5.67 Laval University Company Overview 137

5.67.1 Laval University Pipeline Products & Ongoing Clinical Trials Overview 137

5.68 LifeCodexx AG Company Overview 140

5.68.1 LifeCodexx AG Pipeline Products & Ongoing Clinical Trials Overview 140

5.69 LineaGen Inc Company Overview 141

5.69.1 LineaGen Inc Pipeline Products & Ongoing Clinical Trials Overview 141

5.70 Lucid Diagnostics Inc Company Overview 142

5.70.1 Lucid Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview 142

5.71 Maastricht University Medical Center Company Overview 146

5.71.1 Maastricht University Medical Center Pipeline Products & Ongoing Clinical Trials Overview 146

5.72 Massachusetts Eye and Ear Infirmary Company Overview 147

5.72.1 Massachusetts Eye and Ear Infirmary Pipeline Products & Ongoing Clinical Trials Overview 147

5.73 Max Delbruck Center for Molecular Medicine Company Overview 149

5.73.1 Max Delbruck Center for Molecular Medicine Pipeline Products & Ongoing Clinical Trials Overview 149

5.74 McGill University Company Overview 150

5.74.1 McGill University Pipeline Products & Ongoing Clinical Trials Overview 150

5.75 Medical Research Council Company Overview 151

5.75.1 Medical Research Council Pipeline Products & Ongoing Clinical Trials Overview 151

5.76 MeMed Diagnostics LTD Company Overview 152

5.76.1 MeMed Diagnostics LTD Pipeline Products & Ongoing Clinical Trials Overview 152

5.77 Myriad Genetics Inc Company Overview 153

5.77.1 Myriad Genetics Inc Pipeline Products & Ongoing Clinical Trials Overview 153

5.78 Nanosphere Inc Company Overview 154

5.78.1 Nanosphere Inc Pipeline Products & Ongoing Clinical Trials Overview 154

5.79 National Jewish Health Company Overview 156

5.79.1 National Jewish Health Pipeline Products & Ongoing Clinical Trials Overview 156

5.80 National University of Singapore Company Overview 157

5.80.1 National University of Singapore Pipeline Products & Ongoing Clinical Trials Overview 157

5.81 Nel ASA Company Overview 159

5.81.1 Nel ASA Pipeline Products & Ongoing Clinical Trials Overview 159

5.82 NewGene Ltd Company Overview 160

5.82.1 NewGene Ltd Pipeline Products & Ongoing Clinical Trials Overview 160

5.83 NIPD Genetics Company Overview 163

5.83.1 NIPD Genetics Pipeline Products & Ongoing Clinical Trials Overview 163

5.84 Oxford Biodynamics Plc Company Overview 164

5.84.1 Oxford Biodynamics Plc Pipeline Products & Ongoing Clinical Trials Overview 164

5.85 Oxford Gene Technology Ltd Company Overview 182

5.85.1 Oxford Gene Technology Ltd Pipeline Products & Ongoing Clinical Trials Overview 182

5.86 ParagonDx LLC (Inactive) Company Overview 183

5.86.1 ParagonDx LLC (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 183

5.87 PerkinElmer Inc Company Overview 184

5.87.1 PerkinElmer Inc Pipeline Products & Ongoing Clinical Trials Overview 184

5.88 Population Bio Inc Company Overview 185

5.88.1 Population Bio Inc Pipeline Products & Ongoing Clinical Trials Overview 185

5.89 Precipio Inc Company Overview 195

5.89.1 Precipio Inc Pipeline Products & Ongoing Clinical Trials Overview 195

5.90 PreCyte, Inc. Company Overview 196

5.90.1 PreCyte, Inc. Pipeline Products & Ongoing Clinical Trials Overview 196

5.91 PredictImmune Ltd Company Overview 197

5.91.1 PredictImmune Ltd Pipeline Products & Ongoing Clinical Trials Overview 197

5.92 Predictive Therapeutics LLC Company Overview 200

5.92.1 Predictive Therapeutics LLC Pipeline Products & Ongoing Clinical Trials Overview 200

5.93 Predigen Inc Company Overview 203

5.93.1 Predigen Inc Pipeline Products & Ongoing Clinical Trials Overview 203

5.94 Progenity Inc Company Overview 204

5.94.1 Progenity Inc Pipeline Products & Ongoing Clinical Trials Overview 204

5.95 Proove BioScience Inc Company Overview 205

5.95.1 Proove BioScience Inc Pipeline Products & Ongoing Clinical Trials Overview 205

5.96 Quest Diagnostics Inc Company Overview 208

5.96.1 Quest Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview 208

5.97 Roche Diagnostics International Ltd Company Overview 209

5.97.1 Roche Diagnostics International Ltd Pipeline Products & Ongoing Clinical Trials Overview 209

5.98 Sapien Biosciences Company Overview 210

5.98.1 Sapien Biosciences Pipeline Products & Ongoing Clinical Trials Overview 210

5.99 Scipher Medicine Corp Company Overview 212

5.99.1 Scipher Medicine Corp Pipeline Products & Ongoing Clinical Trials Overview 212

5.100 Seattle Children’s Hospital Company Overview 216

5.100.1 Seattle Children’s Hospital Pipeline Products & Ongoing Clinical Trials Overview 216

5.101 Seegene Inc Company Overview 220

5.101.1 Seegene Inc Pipeline Products & Ongoing Clinical Trials Overview 220

5.102 Sequenom Inc Company Overview 221

5.102.1 Sequenom Inc Pipeline Products & Ongoing Clinical Trials Overview 221

5.103 Sheba Medical Center Company Overview 223

5.103.1 Sheba Medical Center Pipeline Products & Ongoing Clinical Trials Overview 223

5.104 SkylineDx BV Company Overview 224

5.104.1 SkylineDx BV Pipeline Products & Ongoing Clinical Trials Overview 224

5.105 Sophia Genetics SA Company Overview 225

5.105.1 Sophia Genetics SA Pipeline Products & Ongoing Clinical Trials Overview 225

5.106 StellarGene Technologies Pvt Ltd Company Overview 226

5.106.1 StellarGene Technologies Pvt Ltd Pipeline Products & Ongoing Clinical Trials Overview 226

5.107 Strand Life Sciences Pvt Ltd Company Overview 227

5.107.1 Strand Life Sciences Pvt Ltd Pipeline Products & Ongoing Clinical Trials Overview 227

5.108 SUNY Upstate Medical University Company Overview 229

5.108.1 SUNY Upstate Medical University Pipeline Products & Ongoing Clinical Trials Overview 229

5.109 Takeda Pharmaceuticals International AG Company Overview 230

5.109.1 Takeda Pharmaceuticals International AG Pipeline Products & Ongoing Clinical Trials Overview 230

5.110 TAmiRNA GmbH Company Overview 231

5.110.1 TAmiRNA GmbH Pipeline Products & Ongoing Clinical Trials Overview 231

5.111 TBG Diagnostics Ltd Company Overview 232

5.111.1 TBG Diagnostics Ltd Pipeline Products & Ongoing Clinical Trials Overview 232

5.112 Tel Aviv University Company Overview 233

5.112.1 Tel Aviv University Pipeline Products & Ongoing Clinical Trials Overview 233

5.113 The Francis Crick Institute Ltd Company Overview 235

5.113.1 The Francis Crick Institute Ltd Pipeline Products & Ongoing Clinical Trials Overview 235

5.114 thromboDx Company Overview 236

5.114.1 thromboDx Pipeline Products & Ongoing Clinical Trials Overview 236

5.115 Transplant Genomics Inc Company Overview 237

5.115.1 Transplant Genomics Inc Pipeline Products & Ongoing Clinical Trials Overview 237

5.116 Tufts Medical Center Company Overview 239

5.116.1 Tufts Medical Center Pipeline Products & Ongoing Clinical Trials Overview 239

5.117 University Hospital of Cologne Company Overview 240

5.117.1 University Hospital of Cologne Pipeline Products & Ongoing Clinical Trials Overview 240

5.118 University of Arizona Company Overview 243

5.118.1 University of Arizona Pipeline Products & Ongoing Clinical Trials Overview 243

5.119 University of California San Diego Company Overview 244

5.119.1 University of California San Diego Pipeline Products & Ongoing Clinical Trials Overview 244

5.120 University of California San Francisco Company Overview 245

5.120.1 University of California San Francisco Pipeline Products & Ongoing Clinical Trials Overview 245

5.121 University of Cambridge Company Overview 246

5.121.1 University of Cambridge Pipeline Products & Ongoing Clinical Trials Overview 246

5.122 University of Cape Town Company Overview 247

5.122.1 University of Cape Town Pipeline Products & Ongoing Clinical Trials Overview 247

5.123 University of Central Florida Company Overview 248

5.123.1 University of Central Florida Pipeline Products & Ongoing Clinical Trials Overview 248

5.124 University of Colorado Company Overview 250

5.124.1 University of Colorado Pipeline Products & Ongoing Clinical Trials Overview 250

5.125 University of Illinois at Chicago Company Overview 251

5.125.1 University of Illinois at Chicago Pipeline Products & Ongoing Clinical Trials Overview 251

5.126 University of Melbourne Company Overview 252

5.126.1 University of Melbourne Pipeline Products & Ongoing Clinical Trials Overview 252

5.127 University of Michigan Company Overview 253

5.127.1 University of Michigan Pipeline Products & Ongoing Clinical Trials Overview 253

5.128 University of Oxford Company Overview 255

5.128.1 University of Oxford Pipeline Products & Ongoing Clinical Trials Overview 255

5.129 University of Pennsylvania Company Overview 256

5.129.1 University of Pennsylvania Pipeline Products & Ongoing Clinical Trials Overview 256

5.130 University of Pittsburgh Company Overview 257

5.130.1 University of Pittsburgh Pipeline Products & Ongoing Clinical Trials Overview 257

5.131 University of Turku Company Overview 258

5.131.1 University of Turku Pipeline Products & Ongoing Clinical Trials Overview 258

5.132 Vanadis Diagnostics AB Company Overview 259

5.132.1 Vanadis Diagnostics AB Pipeline Products & Ongoing Clinical Trials Overview 259

5.133 Vanderbilt University Company Overview 262

5.133.1 Vanderbilt University Pipeline Products & Ongoing Clinical Trials Overview 262

5.134 Vanessa Research Inc Company Overview 263

5.134.1 Vanessa Research Inc Pipeline Products & Ongoing Clinical Trials Overview 263

5.135 Virginia Commonwealth University Company Overview 264

5.135.1 Virginia Commonwealth University Pipeline Products & Ongoing Clinical Trials Overview 264

5.136 VitaPath Genetics, Inc. Company Overview 265

5.136.1 VitaPath Genetics, Inc. Pipeline Products & Ongoing Clinical Trials Overview 265

5.137 Yale University Company Overview 266

5.137.1 Yale University Pipeline Products & Ongoing Clinical Trials Overview 266

6 Inborn Gene or Chromosome Alterations- Recent Developments 267

6.1 Oct 23, 2020: Yourgene Health: CQC accreditation 267

6.2 Aug 06, 2020: OPKO Health’s GeneDx adds GenomeXpress to its industry-leading clinical genomics portfolio 267

6.3 Jul 31, 2020: Fluidigm selected for $37 million project under National Institutes of Health RADx initiative 268

6.4 Jul 23, 2020: PolyA-miner accurately assesses the effect of alternative polyadenylation on gene expression 269

6.5 Jul 13, 2020: Thermo Fisher Scientific and first genetics JCS partner to develop next-generation sequencing-based diagnostics in Russia 270

6.6 Jul 08, 2020: GenMark Diagnostics: Entry into a Material Definitive Agreement 271

6.7 May 28, 2020: QIAGEN builds on leading position in Precision Medicine with novel solutions in oncology 271

6.8 May 18, 2020: QIAGEN announces publication of Reasoned Position Statement for proposed acquisition by Thermo Fisher and date for Annual General Meeting 272

6.9 May 04, 2020: StageZero Life Sciences announces enhanced relationship with Phleb-Finders 273

6.10 Feb 29, 2020: MGI’s response to Illumina’s complaint 273

6.11 Feb 26, 2020: Thermo Fisher Scientific President and Chief Executive Officer Marc N. Casper elected Chairman of the Board of Directors 273

6.12 Feb 26, 2020: Natera reports fourth quarter and year 2019 financial results 274

6.13 Feb 20, 2020: Oxford BioDynamics to present at BioTech Pharma Summit: Liquid Biopsy 2020 in Lisbon, Portugal 276

6.14 Feb 20, 2020: SOPHiA GENETICS Board of Directors elects Troy Cox as new Chairman 277

6.15 Feb 19, 2020: Invitae reports $216.8 million in annual revenue driven by more than 482,000 samples in 2019 277

6.16 Feb 18, 2020: Hologic Expands Costa Rican operations with new financial shared services center 279

6.17 Feb 13, 2020: LabCorp announces 2019 fourth quarter and full year results and provides 2020 guidance 280

6.18 Feb 12, 2020: Pivotal to provide services to lucid diagnostics´ clinical studies for its GI in-vitro diagnostics Esoguard and Esocheck to facilitate diagnosis of Barrett’s esophagus 283

6.19 Feb 11, 2020: U.S. FDA grants PAVmed Subsidiary, Lucid Diagnostics, Breakthrough Device Designation for its EsoGuard Esophageal DNA Test 284

6.20 Feb 11, 2020: Predictive Technology Group announces beta test results for its ARTguide test 285

6.21 Feb 10, 2020: Luminex reports fourth quarter and full-year 2019 results 286

6.22 Feb 06, 2020: Dr. Scott Gottlieb, former US FDA Commissioner, joins Illumina’s Board of Directors 287

6.23 Feb 06, 2020: Myriad announces leadership transition 288

6.24 Feb 06, 2020: Myriad Genetics reports fiscal second-quarter 2020 financial results 288

6.25 Feb 06, 2020: Dr. Scott Gottlieb, former US FDA Commissioner, joins Illumina’s Board of Directors 290

6.26 Feb 05, 2020: Hologic launches new scalable options for panther system in the United States and Europe 291

6.27 Jan 30, 2020: Quest Diagnostics reports record fourth quarter and full year 2019 revenues and earnings; provides guidance for full year 2020; increases dividend

5.7% to $0.56 per quarter 292

6.28 Jan 30, 2020: Thermo Fisher Scientific reports fourth quarter and full year 2019 results 292

6.29 Jan 27, 2020: Natera files suit against ArcherDX for Patent Infringement 295

6.30 Jan 21, 2020: PredictImmune announces commercial partnership with Cambridge Clinical Laboratories (CCL) to promote and supply PredictSURE IBD, the world’s first validated prognostic test for Inflammatory Bowel Disease 295

6.31 Jan 14, 2020: Fluidigm provides preliminary financial results for fourth quarter and fiscal year 2019 296

6.32 Jan 14, 2020: Dr. Thomas P. Slavin named Senior Vice President of Medical Affairs for Myriad Oncology 296

6.33 Jan 13, 2020: GenMark Diagnostics provides preliminary operational and financial results for 2019 297

6.34 Jan 12, 2020: Hologic announces preliminary financial results for first quarter of fiscal 2020 297

6.35 Jan 12, 2020: Invitae preliminary 2019 financial results demonstrate strong momentum with nearly 60% growth in test volume and more than 45% growth in revenue year-over-year 298

6.36 Jan 06, 2020: Interpace Biosciences announces collaborative study with University of North Carolina to assess the use BarreGEN after Ablation of dysplastic barrett’s esophagus 299

6.37 Jan 06, 2020: Natera announces achievement of $55 million in pharma contracts and issuance of new oncology patents 300

6.38 Jan 02, 2020: Agilent expands cross-vendor CDS instrument control 300

6.39 Dec 29, 2019: Illumina reports financial results for fourth quarter and fiscal year 2019 301

6.40 Dec 24, 2019: Ad-hoc announcement pursuant to article 17 market abuse regulation 303

6.41 Dec 19, 2019: PAVmed subsidiary Lucid Diagnostics announces commercial launch of EsoGuard Esophageal DNA Test 303

6.42 Dec 10, 2019: Fluidigm expands Maxpar antibody portfolio for high-multiplex tissue imaging 304

6.43 Dec 04, 2019: Myriad’s Prequel Prenatal Screen has superior sensitivity in women with high BMI undergoing non-invasive prenatal screening 304

6.44 Dec 03, 2019: genedrive: Antibiotic Induced Hearing Loss assay kit demonstrates high clinical accuracy 305

6.45 Dec 02, 2019: Yourgene Health: Half-year Report 306

6.46 Nov 28, 2019: Yourgene Health: Opening of new facilities and corporate HQ 307

6.47 Nov 26, 2019: MyHeritage adds 9 new reports to its Genetic Health product 307

6.48 Nov 26, 2019: LabCorp appoints senior finance executive Jeffrey A. Davis to its Board of Directors 309

7 Appendix 310

7.1 Methodology 310

7.2 About GlobalData 314

7.3 Contact Us 314

List of Tables

Table 1: Inborn Gene or Chromosome Alterations – Pipeline Products by Stage of Development 22

Table 2: Inborn Gene or Chromosome Alterations – Pipeline Products by Territory 23

Table 3: Inborn Gene or Chromosome Alterations – Pipeline Products by Regulatory Path 24

Table 4: Inborn Gene or Chromosome Alterations – Pipeline Products by Estimated Approval Date 25

Table 5: Inborn Gene or Chromosome Alterations – Ongoing Clinical Trials 26

Table 6: Inborn Gene or Chromosome Alterations Companies – Pipeline Products by Stage of Development 27

Table 7: Inborn Gene or Chromosome Alterations – Pipeline Products by Stage of Development 31

Table 8: Aarhus University Pipeline Products & Ongoing Clinical Trials Overview 38

Table 11: AbaStar MDx Inc Pipeline Products & Ongoing Clinical Trials Overview 39

Table 20: AC-Gen Reading Life S.L. Pipeline Products & Ongoing Clinical Trials Overview 42

Table 23: Agena Bioscience Inc Pipeline Products & Ongoing Clinical Trials Overview 43

Table 26: Alexion Pharmaceuticals Inc Pipeline Products & Ongoing Clinical Trials Overview 44

Table 29: Allele Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview 45

Table 32: Amarantus Bioscience Holdings Inc Pipeline Products & Ongoing Clinical Trials Overview 46

Table 35: Amity University Pipeline Products & Ongoing Clinical Trials Overview 47

Table 38: Arrayit Corporation Pipeline Products & Ongoing Clinical Trials Overview 48

Table 41: Asuragen Inc Pipeline Products & Ongoing Clinical Trials Overview 49

Table 44: Augusta University Pipeline Products & Ongoing Clinical Trials Overview 50

Table 47: AutoGenomics Inc Pipeline Products & Ongoing Clinical Trials Overview 51

Table 56: Baylor College of Medicine Pipeline Products & Ongoing Clinical Trials Overview 54

Table 59: BioCeps (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 55

Table 62: Biocept Inc Pipeline Products & Ongoing Clinical Trials Overview 56

Table 65: Biofidelity Ltd Pipeline Products & Ongoing Clinical Trials Overview 57

Table 68: Boston Children’s Hospital Pipeline Products & Ongoing Clinical Trials Overview 58

Table 73: Cardiff Oncology Inc Pipeline Products & Ongoing Clinical Trials Overview 60

Table 76: CareDx Inc Pipeline Products & Ongoing Clinical Trials Overview 61

Table 85: Celula Inc Pipeline Products & Ongoing Clinical Trials Overview 65

Table 88: Children’s Hospital of Philadelphia Pipeline Products & Ongoing Clinical Trials Overview 66

Table 91: China Medical Technologies Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 67

Table 94: ChipCare Corp Pipeline Products & Ongoing Clinical Trials Overview 68

Table 97: ChromaCode Inc Pipeline Products & Ongoing Clinical Trials Overview 69

Table 100: Chronix Biomedical Inc Pipeline Products & Ongoing Clinical Trials Overview 70

Table 103: Cincinnati Children’s Hospital Medical Center Pipeline Products & Ongoing Clinical Trials Overview 71

Table 114: Columbia University Pipeline Products & Ongoing Clinical Trials Overview 75

Table 121: Consejo Superior de Investigaciones Cientificas Pipeline Products & Ongoing Clinical Trials Overview 77

Table 124: Daan Gene Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 78

Table 127: Decipher GenX, Inc. Pipeline Products & Ongoing Clinical Trials Overview 79

Table 133: Echelon Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview 81

Table 136: EGIS Pharmaceuticals Plc Pipeline Products & Ongoing Clinical Trials Overview 82

Table 139: Eone Diagnomics Genome Center Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 83

Table 148: Epinex Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview 87

Table 151: Fina Biotech SL Pipeline Products & Ongoing Clinical Trials Overview 88

Table 154: Firalis SAS Pipeline Products & Ongoing Clinical Trials Overview 89

Table 157: Fluidigm Corp Pipeline Products & Ongoing Clinical Trials Overview 90

Table 160: Fraunhofer Institute for Cell Therapy and Immunology Pipeline Products & Ongoing Clinical Trials Overview 91

Table 163: Fraunhofer-Gesellschaft zur Forderung der Angewandten Forschung eV Pipeline Products & Ongoing Clinical Trials Overview 92

Table 166: Fred Hutchinson Cancer Research Center Pipeline Products & Ongoing Clinical Trials Overview 93

Table 171: French National Institute of Health and Medical Research Pipeline Products & Ongoing Clinical Trials Overview 95

Table 180: genedrive plc Pipeline Products & Ongoing Clinical Trials Overview 98

Table 185: Genentech USA Inc Pipeline Products & Ongoing Clinical Trials Overview 101

Table 191: Genomic Vision SA Pipeline Products & Ongoing Clinical Trials Overview 103

Table 194: genomiQa Pty Ltd Pipeline Products & Ongoing Clinical Trials Overview 104

Table 201: German Cancer Research Center Pipeline Products & Ongoing Clinical Trials Overview 108

Table 210: German Institute of Human Nutrition Pipeline Products & Ongoing Clinical Trials Overview 111

Table 213: Gilupi GmbH Pipeline Products & Ongoing Clinical Trials Overview 112

Table 216: GnuBIO Inc Pipeline Products & Ongoing Clinical Trials Overview 113

Table 219: Hadassah Medical Center Pipeline Products & Ongoing Clinical Trials Overview 114

Table 222: Hebrew University of Jerusalem Pipeline Products & Ongoing Clinical Trials Overview 115

Table 225: Helicos BioSciences Corporation Pipeline Products & Ongoing Clinical Trials Overview 116

Table 228: Helmholtz Zentrum Munchen Deutsches Forschungszentrum fur Gesundheit und Umwelt (GmbH) Pipeline Products & Ongoing Clinical Trials Overview 117

Table 233: Hummingbird Diagnostics GmbH Pipeline Products & Ongoing Clinical Trials Overview 119

Table 236: iGene Laboratory Pte Ltd Pipeline Products & Ongoing Clinical Trials Overview 120

Table 239: Illumina Inc Pipeline Products & Ongoing Clinical Trials Overview 121

Table 242: Indiana University Pipeline Products & Ongoing Clinical Trials Overview 123

Table 245: Interpace Biosciences Inc Pipeline Products & Ongoing Clinical Trials Overview 124

Table 254: iXlayer Inc Pipeline Products & Ongoing Clinical Trials Overview 129

Table 257: Johns Hopkins University Pipeline Products & Ongoing Clinical Trials Overview 130

Table 264: JS Genetics Inc Pipeline Products & Ongoing Clinical Trials Overview 133

Table 267: Juneau Biosciences LLC Pipeline Products & Ongoing Clinical Trials Overview 134

Table 270: KellBenx Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 135

Table 273: Laboratory Corp of America Holdings Pipeline Products & Ongoing Clinical Trials Overview 136

Table 276: Laval University Pipeline Products & Ongoing Clinical Trials Overview 137

Table 281: LifeCodexx AG Pipeline Products & Ongoing Clinical Trials Overview 140

Table 284: LineaGen Inc Pipeline Products & Ongoing Clinical Trials Overview 141

Table 287: Lucid Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview 142

Table 294: Maastricht University Medical Center Pipeline Products & Ongoing Clinical Trials Overview 146

Table 297: Massachusetts Eye and Ear Infirmary Pipeline Products & Ongoing Clinical Trials Overview 147

Table 302: Max Delbruck Center for Molecular Medicine Pipeline Products & Ongoing Clinical Trials Overview 149

Table 305: McGill University Pipeline Products & Ongoing Clinical Trials Overview 150

Table 308: Medical Research Council Pipeline Products & Ongoing Clinical Trials Overview 151

Table 311: MeMed Diagnostics LTD Pipeline Products & Ongoing Clinical Trials Overview 152

Table 314: Myriad Genetics Inc Pipeline Products & Ongoing Clinical Trials Overview 153

Table 317: Nanosphere Inc Pipeline Products & Ongoing Clinical Trials Overview 154

Table 322: National Jewish Health Pipeline Products & Ongoing Clinical Trials Overview 156

Table 325: National University of Singapore Pipeline Products & Ongoing Clinical Trials Overview 157

Table 330: Nel ASA Pipeline Products & Ongoing Clinical Trials Overview 159

Table 333: NewGene Ltd Pipeline Products & Ongoing Clinical Trials Overview 160

Table 342: NIPD Genetics Pipeline Products & Ongoing Clinical Trials Overview 163

Table 345: Oxford Biodynamics Plc Pipeline Products & Ongoing Clinical Trials Overview 164

Table 392: Oxford Gene Technology Ltd Pipeline Products & Ongoing Clinical Trials Overview 182

Table 395: ParagonDx LLC (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 183

Table 398: PerkinElmer Inc Pipeline Products & Ongoing Clinical Trials Overview 184

Table 401: Population Bio Inc Pipeline Products & Ongoing Clinical Trials Overview 185

Table 430: Precipio Inc Pipeline Products & Ongoing Clinical Trials Overview 195

Table 433: PreCyte, Inc. Pipeline Products & Ongoing Clinical Trials Overview 196

Table 436: PredictImmune Ltd Pipeline Products & Ongoing Clinical Trials Overview 197

Table 440: PredictSURE IBD – Predicting Crohn’s & ColitIs Outcomes in the United States: The PRECIOUS Study 199

Table 442: Predictive Therapeutics LLC Pipeline Products & Ongoing Clinical Trials Overview 200

Table 449: Predigen Inc Pipeline Products & Ongoing Clinical Trials Overview 203

Table 452: Progenity Inc Pipeline Products & Ongoing Clinical Trials Overview 204

Table 455: Proove BioScience Inc Pipeline Products & Ongoing Clinical Trials Overview 205

Table 464: Quest Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview 208

Table 467: Roche Diagnostics International Ltd Pipeline Products & Ongoing Clinical Trials Overview 209

Table 470: Sapien Biosciences Pipeline Products & Ongoing Clinical Trials Overview 210

Table 477: Scipher Medicine Corp Pipeline Products & Ongoing Clinical Trials Overview 212

Table 484: Seattle Children’s Hospital Pipeline Products & Ongoing Clinical Trials Overview 216

Table 491: Seegene Inc Pipeline Products & Ongoing Clinical Trials Overview 220

Table 494: Sequenom Inc Pipeline Products & Ongoing Clinical Trials Overview 221

Table 499: Sheba Medical Center Pipeline Products & Ongoing Clinical Trials Overview 223

Table 502: SkylineDx BV Pipeline Products & Ongoing Clinical Trials Overview 224

Table 505: Sophia Genetics SA Pipeline Products & Ongoing Clinical Trials Overview 225

Table 508: StellarGene Technologies Pvt Ltd Pipeline Products & Ongoing Clinical Trials Overview 226

Table 511: Strand Life Sciences Pvt Ltd Pipeline Products & Ongoing Clinical Trials Overview 227

Table 516: SUNY Upstate Medical University Pipeline Products & Ongoing Clinical Trials Overview 229

Table 519: Takeda Pharmaceuticals International AG Pipeline Products & Ongoing Clinical Trials Overview 230

Table 522: TAmiRNA GmbH Pipeline Products & Ongoing Clinical Trials Overview 231

Table 525: TBG Diagnostics Ltd Pipeline Products & Ongoing Clinical Trials Overview 232

Table 528: Tel Aviv University Pipeline Products & Ongoing Clinical Trials Overview 233

Table 533: The Francis Crick Institute Ltd Pipeline Products & Ongoing Clinical Trials Overview 235

Table 536: thromboDx Pipeline Products & Ongoing Clinical Trials Overview 236

Table 539: Transplant Genomics Inc Pipeline Products & Ongoing Clinical Trials Overview 237

Table 544: Tufts Medical Center Pipeline Products & Ongoing Clinical Trials Overview 239

Table 547: University Hospital of Cologne Pipeline Products & Ongoing Clinical Trials Overview 240

Table 556: University of Arizona Pipeline Products & Ongoing Clinical Trials Overview 243

Table 559: University of California San Diego Pipeline Products & Ongoing Clinical Trials Overview 244

Table 562: University of California San Francisco Pipeline Products & Ongoing Clinical Trials Overview 245

Table 565: University of Cambridge Pipeline Products & Ongoing Clinical Trials Overview 246

Table 568: University of Cape Town Pipeline Products & Ongoing Clinical Trials Overview 247

Table 571: University of Central Florida Pipeline Products & Ongoing Clinical Trials Overview 248

Table 576: University of Colorado Pipeline Products & Ongoing Clinical Trials Overview 250

Table 579: University of Illinois at Chicago Pipeline Products & Ongoing Clinical Trials Overview 251

Table 582: University of Melbourne Pipeline Products & Ongoing Clinical Trials Overview 252

Table 585: University of Michigan Pipeline Products & Ongoing Clinical Trials Overview 253

Table 590: University of Oxford Pipeline Products & Ongoing Clinical Trials Overview 255

Table 593: University of Pennsylvania Pipeline Products & Ongoing Clinical Trials Overview 256

Table 596: University of Pittsburgh Pipeline Products & Ongoing Clinical Trials Overview 257

Table 599: University of Turku Pipeline Products & Ongoing Clinical Trials Overview 258

Table 602: Vanadis Diagnostics AB Pipeline Products & Ongoing Clinical Trials Overview 259

Table 607: Vanderbilt University Pipeline Products & Ongoing Clinical Trials Overview 262

Table 610: Vanessa Research Inc Pipeline Products & Ongoing Clinical Trials Overview 263

Table 613: Virginia Commonwealth University Pipeline Products & Ongoing Clinical Trials Overview 264

Table 616: VitaPath Genetics, Inc. Pipeline Products & Ongoing Clinical Trials Overview 265

Table 619: Yale University Pipeline Products & Ongoing Clinical Trials Overview 266

Table 622: Glossary 313

List of Figures

Figure 1: Inborn Gene or Chromosome Alterations – Pipeline Products by Stage of Development 22

Figure 2: Inborn Gene or Chromosome Alterations – Pipeline Products by Territory 23

Figure 3: Inborn Gene or Chromosome Alterations – Pipeline Products by Regulatory Path 24

Figure 4: Inborn Gene or Chromosome Alterations – Pipeline Products by Estimated Approval Date 25

Figure 5: Inborn Gene or Chromosome Alterations – Ongoing Clinical Trials 26

    Pricing

Discounts available for multiple report purchases.

reportstore@globaldata.com
+44 20 7947 2745

Join our mailing list

Saved reports